REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

NCT02291809 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV/AIDS

Interventions

BIOLOGICAL: REMUNE

Sponsor

Immune Response BioPharma, Inc.